3D-printing of devices will overtake drugs
This article was originally published in Clinica
Executive Summary
As the cost of 3D printing comes down and becomes more competitively priced with existing manufacturing technologies, 3D-printed medical devices and prosthetics will become more common over the next 10 years. On the other hand, 3D-printed drugs will find it more challenging to overcome cost hurdles, thus making it more unlikely for drugs to be manufactured widely using this technology.